Publications
Only in the last 10 years are listed.
2017
Smith A, Javed S, Barad A, Myhre V, Li WM, Reimer K, Massicotte HB, Tackaberry LE, Payne G, Egger KN, Lee CH. (2017) Anti-proliferative and immuno-modulatory activities of fungi from north-central British Columbia. Int J Med Mushroom 19(6):
Li WM, Chan CM, Miller AL, Lee CH. (2017) Live-imaging of miR-430 in the developing zebrafish embryo using a specific molecular beacon. J Biol Chem 292:3568-3580
Rensburg GV, Mackedenski S, Lee CH. (2017) Characterizing the coding region determinant-binding protein-microphthalmia-associated transcription factor mRNA interaction. PLOS ONE 12(2):e0171196.
2016
Mehmood K, Akhtar D, Mackedenski S, Wang C, Lee CH. (2016) Inhibition of GLI1 expression by targeting the CRD-BP-GLI1 mRNA interaction using specific oligonucleotide. Mol Pharmacol 89:606-617.
2015:
Chohan M, Mackedenski S, Li WM, Lee CH. (2015) Human apurinic/apyrimidinic endonuclease 1 (APE1) has 3’ RNA phosphatase and 3’ exoribonuclease activities. J Mol Biol 427:298-311.
Barnes M, Rensburg GV, Li WM, Mehmood K, Mackedenski S, Chan CM, King DT, Miller AL, Lee CH. (2015) Molecular insights into the CRD-BP-RNA interaction through site-directed mutagenesis in the heterogeneous nuclear ribonucleoprotein-K-homology domains. J Biol Chem 290:625-639.
2014:
Lee CH. (2014) DNA repair meets the RNA world. Antioxid Redox Signal 20:618-620.
King DT, Barnes M, Thomsen D, Lee CH. (2014) Assessing specific oligonucleotides and small molecule antibiotics for ability to inhibit the CRD-BP-CD44 RNA interaction. PLoS ONE 9:e91585.
Kim W-C, Ma C, Li WM, Wilson DM III, Lee CH. (2014) Altered endoribonuclease activity of APE1 variants identified in the human population. PLoS ONE 9:e90837.
2011:
Kim W-C, Berquist BR, Chohan M, Uy C, Wilson DM III, Lee CH. (2011) Characterization of the endoribonuclease active site of human apurinic/apyrimidinic endonuclease 1 (APE1). J Mol Biol 411 :960-971.
2010:
Kim S-E, Gorrell A, Rader S, Lee CH. (2010) Endoribonuclease activity of human APE1 revealed by a real-time fluorometric assay. Anal Biochem 398: 69-75.
Tell G, Wilson DM III, Lee CH. (2010) Intrusion of a DNA-repair protein in the RNome world: is this a beginning of a new era? Mol Cell Biol 30: 366-371.
Li W-M, Barnes T, Lee CH. (2010) Endoribonucleases: enzymes gaining spotlight in mRNA metabolism. FEBS J 277: 627-641.
Kim W-C, King D, Lee CH. (2010) RNA-cleaving properties of human apurinic/apyrimidinic endonuclease1 (APE1). Int J Biochem Mol Biol 1: 12-25.
Lee CH. (2010) Reversing agents for ATP-binding cassette drug transporters. Methods Mol Biol 596: 325-340.
2009:
Barnes T, Kim W-C, Mantha A, Kim S-E, Izumi T, Sankar M, Lee CH. (2009) Identification of apurinic/apyrimidinic endonuclease APE1 as the endoribonuclease that cleaves c-myc mRNA. Nucleic Acids Res. 37: 3946-3958.
Kim W-C, Lee CH. (2009) The role of mammalian ribonucleases (RNases) in cancer. Biochim Biophys Acta-Reviews on Cancer 1796: 99-113.
2008:
Bassett T, Harpur B, Kuo HK, Lee CH. (2008) Effective stimulation of growth in MCF-7 human breast cancer cells by inhibition of syntaxin18 by external guide sequence and ribonuclease P. Cancer Letts 272:167-175.
2007:
Tafech A, Bennett W, Mills F, Lee CH. (2007) Identification of c-myc coding region determinant RNA sequences and structures cleaved by an RNase1-like endoribonuclease. Biochim Biophys Acta 1769: 49-60.
Sparanese D, Lee CH. (2007) CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease. Nucleic Acids Res 35: 1209-1221.
